Theravance Biopharma shares owned by UBS Group
Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Theravance Biopharma
Tip: Access up to 7 years of quarterly data
All positions including Theravance Biopharma held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Theravance Biopharma by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $798k | 71k | 11.24 |
| 2023-09-30 | $464k | 54k | 8.63 |
| 2023-06-30 | $442k | 43k | 10.35 |
| 2023-03-31 | $290k | 27k | 10.85 |
| 2022-12-31 | $97k | 8.7k | 11.22 |
| 2022-09-30 | $1.0k | 100 | 10.00 |
| 2022-06-30 | $0 | 293 | 0.00 |
| 2022-03-31 | $28k | 3.5k | 8.00 |
| 2021-12-31 | $29k | 2.4k | 12.00 |
| 2021-09-30 | $7.7k | 765 | 10.00 |
| 2021-06-30 | $1.0k | 100 | 10.00 |
| 2021-03-31 | $4.5M | 219k | 20.41 |
| 2020-12-31 | $3.4M | 168k | 20.00 |
| 2020-09-30 | $1.2M | 83k | 14.65 |
| 2020-06-30 | $53k | 2.5k | 20.99 |
| 2020-03-31 | $104k | 4.5k | 23.22 |
| 2019-12-31 | $65k | 2.5k | 25.74 |
| 2019-09-30 | $3.9M | 200k | 19.48 |
| 2019-06-30 | $123k | 7.6k | 16.28 |
| 2019-03-31 | $112k | 4.9k | 22.64 |
| 2018-12-31 | $749k | 30k | 25.40 |
| 2018-09-30 | $201k | 6.2k | 32.53 |
| 2018-06-30 | $70k | 3.1k | 22.69 |
| 2018-03-31 | $109k | 4.5k | 24.16 |
| 2017-12-31 | $67k | 2.4k | 28.13 |
| 2017-09-30 | $247k | 7.2k | 34.26 |
| 2017-06-30 | $96k | 2.4k | 39.47 |
| 2017-03-31 | $7.0k | 200 | 35.00 |
| 2016-12-31 | $6.0k | 200 | 30.00 |
| 2016-09-30 | $118k | 3.3k | 36.07 |
| 2016-06-30 | $19k | 964 | 20.00 |
| 2016-03-31 | $26k | 1.4k | 18.00 |
| 2015-12-31 | $91k | 5.6k | 16.40 |
| 2015-09-30 | $6.0k | 500 | 12.00 |
| 2015-03-31 | $14k | 874 | 16.04 |